, immune and reproduction system functions 8, 9 , sensory perception 10, 11 , self and social awareness 12 and other idiosyncrasies of our physiology, anatomy and behaviour 13 . Although computational predictions of function can be made from large data sets, determining which sequences are functionally related to complex, lineage-specific phenotypes can likely be accomplished only by experimental investigation.
One potentially appealing experimental strategy is to investigate the functional effects of human-lineage specific (HLS) sequences in transgenic non-human primates (NHPs). Ideally, the species chosen for this research should be those that share the greatest genetic similarity with H. sapiens to increase the likelihood that they will express the HLS sequences in ways that give a clear indication of their function in humans. Although the long generation times of apes makes them less than ideal for genetic studies, the high level of similarity between their genetic background and that of humans makes them an attractive host species for transgenic studies of the function of HLS sequences. However, we argue that the scientific insights that can potentially be gained by this approach are outweighed by ethical concerns regarding the generation of such 'humanized' apes. The same evolutionary proximity that makes this research strategy attractive renders it ethically unacceptable in apes, including greater apes (chimpanzees, orangutans, bonobos and gorillas) and lesser apes (gibbons), because apes have the greatest potential to produce human-like phenotypes and, as such, carry a unique potential for harm.
Human lineage-specific sequences
In addition to the human genome sequence 14 , we now have the complete draft genome sequences of chimpanzee 4 and rhesus macaque 15 . Draft assemblies are currently available for the gorilla, orangutan, marmoset and lemur (see Further information for a link to the Ensembl database), and a draft Neanderthal genome sequence has recently been published 16 . Draft sequences of the bonobo and baboon are also underway (see Further information for a link to the National Human Genome Research Institute's Approved Sequencing Targets Information). These data sets provide a rich and unprecedented resource for mining lineage-specific genomic changes among humans and NHPs. Evolutionary genomics has already uncovered a wide range of HLS sequences. Genes affected include those that show striking HLS increases or decreases in copy number [17] [18] [19] , genes that have changed dramatically at the sequence level specifically in humans 20 and genes that show altered brain expression between human and chimpanzee 21, 22 . These genes span a range of functional characteristics, from those with no known function to those implicated in various anatomical and physiological processes 5 , including several genes linked to higher cognitive functions [21] [22] [23] . We can expect that, as more primate genomes are completed, the list of HLS genomic changes will substantially expand and further stimulate interest in understanding the functional consequences of such changes. This in turn can be expected to generate an increased interest in using transgenic animals as a means of studying HLS gene function.
Transgenic research using NHPs For uniquely human sequences or genes, transgenic research using NHPs could likely be accomplished with existing techniques, through exchange of an HLS sequence with a homologous sequence of the transgenic host species or through addition of HLS sequences to the host genome [24] [25] [26] [27] . However, new advances will be required to study the functional consequences of differences in gene expression, as precisely altering expression levels in Abstract | A flood of comparative genomic data is resulting in the identification of human lineage-specific (HLS) sequences. As apes are our closest evolutionary relatives, transgenic introduction of HLS sequences into these species has the greatest potential to produce 'humanized' phenotypes and also to illuminate the functions of these sequences. We argue that such transgenic apes would also be more likely than other species to experience harm from such research, which renders such studies ethically unacceptable in apes and justifies regulatory barriers between these species and other non-human primates for HLS transgenic research.
PerSPectiveS transgenic research by increasing copy number or modifying the regulatory region of a gene remains technically challenging. Nevertheless, improving our abilities to control the number and genomic location of copies of integrated transgenes and levels of temporal and spatial expression is a high priority in human gene transfer research, owing to the crucial implications for the safety and efficacy of human gene therapy and other treatments.
Transgenic technology has commonly been applied to generate mouse models to study several human disorders, including neurodegenerative disorders 28 , autoimmune diseases 29, 30 and cancer 31 . There are also National Institutes of Health (NIH)-supported efforts aimed at humanizing mice by developing transgenic strains that contain human-specific alleles (see Further information for a link to the NIH Requests For Applications (number RFA-mH-08-050)), and a recent study has examined the function of human alleles of the forkhead box P2 (FOXP2) gene in transgenic mice 32 . However, there are limits to what scientists can learn about the function of human genetic sequences in mice because of the substantially different genetic backgrounds of the two species and their considerable anatomical and physiological differences. In particular, there are large differences between rodents and humans in the relative size and composition of the areas of the brain associated with higher cognition. Thus, the possibility that anything near human cognition would result from HLS sequences transferred to a mouse using conventional transgenic approaches is remote.
Recently, there has been a shift towards using transgenic NHP models for disease research. The first transgenic NHP was produced in 2001 (Ref. 26) and, in 2008, a rhesus macaque that showed hallmark features of Huntington's disease became the first transgenic monkey model of human disease, raising the hope of ultimately developing new therapies 27, 33 . Another experimental approach is the recently reported generation of transgenic NHPs to study mitochondrial gene replacement in primate offspring 24 . The goal of developing new therapeutic approaches using these methods is an admirable one, yet it raises important ethical questions about the possible extension of studies using transgenic apes for studying the function of HLS sequences. We argue that there is a need to distinguish between the use of apes and all other NHPs (which we refer to as 'monkeys' hereafter) for such research.
The basic rationale for pursuing transgenic research on HLS sequences is that it could provide important information regarding the basic scientific question of what makes members of H. sapiens different from their nearest evolutionary relatives. The results of such research may also produce clinical benefits, especially given that HLS gene variants have been found to be disproportionately enriched in genomic locations implicated in human diseases 19, 21 , and that rapid genomic changes in the human lineage are often thought to produce human disease as a by-product 25 . It is possible that HLS variants that affect human phenotype could provide important insights into disorders and clinically relevant phenotypes that are difficult to study by other means -including cognitive disease 25 , neurodegenerative disorders 34 , social behaviour disorders such as autism 35 , dementia 36 and speech articulation defects 37, 21 -and gene delivery systems 34 for therapeutic use. As this research is still in its early stages and its benefits are still theoretical, it is appropriate to proactively examine the ethical concerns related to NHP transgenic research.
Animal welfare regulations
The prospect of conducting transgenic NHP research differs according to country; no international animal welfare regulations exist at present, although recently the OIE World Assembly of National Delegates approved a fifth strategic plan for implementing the OIE global objectives in animal health and welfare 38 . Currently, transgenic research involving any NHP could be approved in some countries, including the united States and China, which have no specific bans on this type of research [39] [40] [41] [42] [43] . The use of great apes for most research is effectively banned in the united Kingdom, New Zealand, the Netherlands, Austria and Sweden [44] [45] [46] , and the ban in Austria and Sweden also includes the lesser apes 47 . The European union is now considering updates to their animal welfare laws that would mirror requirements in the united Kingdom 48 . Although monkeys are used for research in the united Kingdom, regulations require additional oversight, including a special license for the individual researcher, project and institution 43, 49 . Animal welfare regulations and guidelines vary around the world, but all share a commitment to the 'Three Rs': replacement, reduction and refinement. The Three Rs state that animals should only be used if there is no alternative and, when animals are necessary, only the most humane methods should be used on the smallest number of animals required for scientific validity 39, 41, 45, [50] [51] [52] . However, the Three Rs are criticized by some for not providing a way to give special consideration to certain species such as NHPs 42 .
The ethical issues
The ethical concerns raised by the production of human-non-human chimaeras that could result from the transplantation of human brain or retinal stem cells to nonhuman embryos or fetuses are addressed in the literature [53] [54] [55] [56] . Stem cell chimaera research differs from transgenic research in that chimaeras are produced by combining cells (full genomes) of one species with those of another, in contrast to adding or deleting one or several genomic sequences in a host animal through transgenics. Thus, ethical oversight of transgenic research will differ in some aspects from the framework developed for chimaera research owing to differences in scientific procedures. For these reasons, the factors and concerns surrounding the oversight of HLS sequences in transgenic research merit a detailed ethical analysis particular to this research. This article anticipates that discussion by focusing on the ethical concerns regarding the likely harm to humanized apes and the ambiguities inherent in determining our ethical obligations to them.
Predictive and diagnostic uncertainty in transgenic NHP research. The transfer of an HLS gene or genomic variant into a NHP could have a specific, discrete effect that has a more or less dramatic impact on a phenotype of relevance to human function. However, biomolecular systems are interdependent and most genes seem to have multiple functions that can be apparently unrelated. So, such a gene transfer could equally have a wide array of unexpected and/or deleterious effects. For example, even if gene targeting could be carried …even if gene targeting could be carried out specifically, the pleiotropic nature of most genes would often make the phenotypic impact of a transgenic intervention extremely difficult to predict or interpret.
out specifically, the pleiotropic nature of most genes would often make the phenotypic impact of a transgenic intervention extremely difficult to predict or interpret. Furthermore, the effect might not emerge immediately but only as offspring are produced, even if the transgene is studied first in other animals 21, 57 . This uncertainty raises the risk of producing unanticipated harm to transgenic NHPs. moreover, if HLS gene transfer accomplishes its intended aim and produces a measurable change in a 'human-like' NHP phenotype, this would raise another set of ethical concerns. Even if a transgenic NHP displayed phenotypic traits that made it only slightly more similar to a human there would be further ethical questions concerning the vulnerability of the animal to harm.
Ethical obligations towards NHPs in transgenic research.
Animal welfare in general, and the use of primates in particular, is often debated in the literature in terms of 'moral status' , a term meant to describe what entities are owed in their own right rather than their instrumental value to others 58, 59 . moral status is not an all-or-nothing assessment as ethically justified regulations allow research on humans and prohibit capricious animal use. Additionally, consideration of our ethical obligations to humans and animals is not dependent on inherent capacities alone but also includes relationship elements. For example, this consideration is applied to humans who lack many human capacities and to companion animals, such as cats, dogs and horses, which lack higher order capacities. merely labelling an entity as having or lacking moral status cannot do the ethical work of sorting out our particular obligations. Rather, ethical obligations should be determined by carefully assessing the answers to at least five questions. What are the goals of research? What is the probability of success? Which animals are to be used? What effect will there be on the animals used? Are there any alternatives? These questions represent a moderate approach to the ethics of animal research: they assume that some animal research is warranted and can be ethically justified, and also recognize that not every scientific finding automatically outweighs the interests and welfare of the animals that demonstrating that finding might require 60 . The literature is growing on ethical issues in the creation and research use of transgenic animals in general and primates in particular. Some analysts try to articulate the unique concerns in transgenic research in terms of the 'unnaturalness' of 'crossing species boundaries' , citing unspecified downstream evolutionary and ecological risks 61, 62 . Others turn to notions of 'animal integrity' or 'species-specific dignity' to try to focus their critiques on the effect of transgenic manipulations on the animals 54, [63] [64] [65] . This approach is headed in the right direction, but it usually remains at a relatively abstract level that is hard to apply to the conduct of animal research.
It can be both strengthened and sharpened by considering the purely biological challenges that would be faced by any transgenic ape that expressed a humanized phenotype. At the far end of the spectrum are cognitive changes that might give transgenic apes enough self-awareness to appreciate the ways their lives are circumscribed and to suffer, albeit immeasurably, in the full psychological sense of that term. but it is not necessary to go that far. Imagine the life of the transgenic chimpanzee that, although no more self-aware than other chimpanzees, is hairless, walks erect, lacks long canine teeth or vocalizes like a human. There may be no question of a 'normal' primate life in the wild for this chimpanzee: it is likely to be condemned by its engineering to live in an artificial environment and to depend on humans for its welfare. Outside the laboratory, this chimpanzee could be considered a grotesque curiosity and unusually susceptible to exploitation and inappropriate treatment for commercial gain. In the laboratory colony, moreover, the transgenic chimpanzee is unlikely to be able to be socially successful with its own species and might be potentially viewed as strange and an outcast by those without its differences. Ill-suited for both the animal and human worlds, the humanized chimpanzee is likely to sustain more injuries and encounter more privations than non-engineered members of either species.
Apes share many capacities with humans, such as the capacity for attachment and empathy, communication, internalization of social rules, giving, trading, revenge, social maintenance and attending to group boundaries. Altering such capacities could exacerbate harm to these animals. Even if the only effect of humanizing expressions of HLS sequences served to inhibit or destroy the characteristics that these apes already share with us, we have harmed them, even from a human 'speciesist' point of view. It is hard to imagine a case in which apes transgenic for HLS sequences would not experience these social harms and the physical welfare concerns they would generate. Therefore, it is reasonable to conclude that this research will almost never be ethically acceptable. With respect to policy, this conclusion supports higher regulatory barriers, in terms of safeguards and review, against any such transgenic HLS sequence research with apes.
Of course, monkeys also display many of these same social and behavioural characteristics. To that extent, should they enjoy the same protections as apes when it comes to transgenic research with HLS sequences? Clearly there is an evolutionary spectrum among NHP species and any line drawing that occurs across it will be to some extent arbitrary. The evolutionary and genomic distance between monkeys and humans is great enough to diminish the prospect that one or a few HLS sequence insertions in a monkey genome will produce human-like phenotypes, or that those phenotypes will be as socially challenging for monkeys as they would be for apes. For the same reason, humanized apes would be at greater risk of exploitation. From the ethical point of view, the more social and cognitive capacities primates possess, the weightier our obligations to them become. However, if a line is needed for policy and regulatory purposes, the line between the ape and monkeys is relatively clear. This reduced risk of harm of a human-like phenotype suggests that transgenic HLS sequence research with monkeys may not always be ethically objectionable and could be regulated on a caseby-case basis by institutional animal care and use committees, including public representation in the form of community members.
Conclusions
A few conclusions can be drawn from this discussion. First, because apes have the greatest potential to functionally express HLS sequences as they are expressed in H. sapiens, they are most at risk of experiencing harm and exploitation following Imagine the life of the transgenic chimpanzee that, although no more self-aware than other chimpanzees, is hairless, walks erect, lacks long canine teeth or vocalizes like a human.
such transgenic research. Second, the challenge of assessing our ethical obligations to humanized apes is profound. The ethical concerns raised by the generation and use of apes as transgenic hosts to study HLS sequence function render this research ethically unacceptable, justifying regulatory barriers between these species and monkeys. Concurrently, we recommend that the possible use of monkeys in transgenic HLS research should be examined on a case-by-case basis by animal welfare review boards, with special attention paid to the unique transgenic issues in careful application of the Three Rs in primate research. Some information regarding HLS gene function can potentially be obtained using HLS transgenic mice. Another alternative would be to use the clues given to us by comparative identification of HLS sequences in further studies of members of our own species. Although the NHP genome is similar to ours, there are also substantial differences. Thus, there are limits to what we can learn about the function of HLS variants until we study them in the human genome in which they may exist as naturally occurring variations. by this more direct means, we can potentially identify deficiencies or mutations in HLS sequences and phenotypes that seem to accompany these changes. Human HLS research is also laden with serious ethical questions about what it might mean for a human to lack the hallmarks of 'humanness' , and how that research might be used and potential harms and abuses avoided. These ethical questions deserve their own further analysis.
